Once-daily administration of atomoxetine is an effective treatment for children and adolescents with ADHD.

No abstract

This cohort study assesses the prevalence of myocarditis in athletes with COVID-19 and compare screening strategies for safe return to play.

Response was significantly greater with osmotically released methylphenidate than with atomoxetine. One-third of patients who received methylphenidate followed by atomoxetine responded better to one or the other, suggesting that there may be preferential responders.

No abstract